For many patients, the primary concern is the quality of the skin itself:
- Hydration
- Fine texture
- Elasticity
- Surface smoothness
- Fine lines
- Photodamage
- Dull appearance
- Selected scar-related changes
- Overall skin quality
A growing range of injectable and minimally invasive treatments is marketed for these concerns.
These include:
- Polynucleotides
- PN/PDRN-based treatments
- Skin boosters
- Hyaluronic-acid-based skin-quality injectables
- Amino-acid formulations
- NCTF-type formulations
- Jalupro treatments
- PRP
- Collagen-stimulating treatments
- Selected exosome-based applications
- Microneedling-based combination treatments
However, these treatments are not interchangeable.
The important question is not:
“Which product is most popular?”
It is:
“What biological problem are we trying to improve?”
What Does “Skin Quality” Mean?
Skin quality is not one measurable characteristic.
It includes several components:
- Hydration
- Epidermal quality
- Dermal thickness
- Elasticity
- Surface texture
- Pigmentation
- Vascular appearance
- Fine wrinkling
- Sebaceous activity
- Scar characteristics
A patient may have excellent facial volume but poor skin quality.
Another patient may have healthy skin but significant:
- Facial volume loss
- Jowling
- Brow descent
- Eyelid excess
These patients do not require the same treatment.
Skin Quality is Different from Facial Volume
This distinction is fundamental.
A skin-quality treatment should not automatically be used to correct structural volume loss.
Similarly, a volumizing filler should not automatically be used when the primary problem is skin quality.
For example:
Poor hydration ≠ volume deficiency
Fine crepey skin ≠ skeletal deficiency
Jowling ≠ poor skin quality
Correctly identifying the anatomical level of the problem prevents unnecessary treatment.
What Are Regenerative Aesthetic Treatments?
“Regenerative aesthetics” is increasingly used to describe treatments intended to interact with biological repair, extracellular matrix remodeling or tissue-quality pathways.
However, the term is broad and sometimes used excessively in marketing.
A treatment should not be called “regenerative” merely because it is injected into the skin.
Likewise:
regenerative treatment does not mean stem-cell treatment.
The biological mechanism and evidence depend on the actual product.
Polynucleotides
Polynucleotide-based injectable products contain purified nucleotide polymers.
They are used in aesthetic medicine primarily in skin-quality treatment strategies.
Potential treatment objectives may include improvement in selected aspects of:
- Hydration
- Texture
- Elasticity
- Fine lines
- Overall skin appearance
depending on the product and indication.
They should not be described as simply “filler.”
Their principal objective is not large-volume structural augmentation.
What is “Salmon DNA”?
“Salmon DNA” is a popular marketing expression used for certain polynucleotide or PDRN-related products derived from purified nucleic-acid material.
The term can be misleading because it may make patients imagine that foreign genetic material is being used to alter their DNA.
That is not the objective.
These products do not rewrite the patient's genetic code.
A more medically meaningful description is based on the specific:
- PN
- PDRN
formulation being used.
PN and PDRN: Are They the Same?
The terms are often used interchangeably in aesthetic marketing, but they should not automatically be treated as identical.
PN — Polynucleotides
refers broadly to longer nucleotide polymers.
PDRN — Polydeoxyribonucleotide
refers to DNA-derived fragments with distinct biological and pharmacological characteristics.
Commercial products can differ in:
- Molecular characteristics
- Concentration
- Formulation
- Manufacturing process
- Intended indication
Therefore, the exact product matters more than the phrase “salmon DNA.”
Are Polynucleotides Fillers?
Not in the conventional volumizing sense.
A traditional dermal filler may be selected to create:
- Projection
- Structural support
- Contour
- Volume replacement
Polynucleotide treatments are generally directed more toward skin quality.
Some transient volume may be visible after injection because of the injected material and edema, but this should not be confused with structural facial augmentation.
Polynucleotides Around the Eyes
The periorbital region is one of the areas where skin-quality treatments are frequently requested.
Selected patients may seek improvement in:
- Fine crepey texture
- Fine lines
- Thin-appearing skin
- Overall periocular skin quality
However, “dark circles” are not one diagnosis.
They can result from:
- Pigmentation
- Thin skin
- Visible vessels
- Tear-trough anatomy
- Orbital fat changes
- Shadowing
- Malar edema
A skin-quality injectable cannot correct every cause.
Skin Boosters
“Skin booster” generally describes injectable products designed primarily to improve skin characteristics rather than create major structural volume.
Many contain hyaluronic acid in formulations that differ from traditional volumizing fillers.
Potential goals can include:
- Hydration
- Smoothness
- Elasticity
- Fine texture
The category includes different products and should not be treated as one standardized treatment.
Skin Booster vs Filler
Both may contain hyaluronic acid, but the intended tissue effect can be very different.
A structural filler may be designed to:
- Maintain projection
- Support tissue
- Shape contours
A skin booster is generally intended to integrate more diffusely and address skin-quality characteristics.
Therefore:
same ingredient family does not mean same clinical function.
Nctf-type Treatments
NCTF-type formulations are multi-component injectable products used in selected skin-quality protocols.
They may contain combinations of ingredients such as:
- Non-cross-linked hyaluronic acid
- Amino acids
- Vitamins
- Minerals
- Coenzymes
- Other components
depending on the specific formulation.
They should not be described simply as “vitamin injections.”
The exact commercial formulation and indication matter.
Jalupro
Jalupro represents a family of injectable skin-quality products based on specific combinations of ingredients, including amino-acid and hyaluronic-acid-related formulations depending on the product.
Its role should be considered according to:
- Skin characteristics
- Treatment area
- Desired tissue effect
- Specific formulation
rather than simply treating it as another generic mesotherapy cocktail.
Amino-acid-based Injectables
Amino acids participate in normal tissue metabolism and protein synthesis.
Some aesthetic injectable formulations incorporate amino acids as part of skin-quality treatment strategies.
However:
injecting amino acids does not automatically mean the skin will produce a predetermined amount of new collagen.
Biological responses are more complex.
Hyaluronic Acid Skin-quality Treatments
Hyaluronic acid has important relationships with tissue hydration and extracellular matrix biology.
However, HA products differ considerably.
They can vary in:
- Concentration
- Molecular characteristics
- Cross-linking
- Rheology
- Tissue integration
- Intended injection plane
A volumizing filler and a skin-quality HA injectable should therefore not be considered interchangeable.
PRP
Platelet-rich plasma is prepared from the patient's own blood.
It contains concentrated platelets and associated biological mediators.
PRP has been investigated for a variety of applications in:
- Skin quality
- Hair-related treatment
- Wound healing
- Scar-related treatment
However:
PRP is not stem-cell therapy.
It should also not be marketed as a guaranteed method of regenerating young skin.
PRP vs Polynucleotides
These are biologically different treatments.
PRP → autologous blood-derived preparation
Polynucleotides → manufactured nucleotide-based injectable products
One is not automatically superior to the other.
The decision should depend on the treatment objective and patient.
Collagen Stimulators
Some injectable materials are designed primarily to stimulate a tissue response that leads to gradual collagen-related structural change.
These are different from conventional skin boosters.
Depending on the material and indication, collagen stimulators can produce effects over time rather than immediate conventional filler-like volume.
Importantly:
collagen stimulator does not mean unlimited or perfectly predictable collagen production.
Product selection, anatomical plane and injection technique matter.
Skin Booster vs Collagen Stimulator
This distinction is useful.
Skin booster → primarily skin hydration/quality
Collagen stimulator → intended to produce a more sustained tissue response and collagen-related remodeling
Some products may have overlapping characteristics, but they should not all be placed in one vague “youth injection” category.
Exosome Applications
Exosomes are extracellular vesicles involved in intercellular communication.
They can contain biological signaling molecules.
Interest in exosome-based technologies has grown rapidly in regenerative medicine and aesthetics.
However, this is also an area where marketing frequently runs ahead of clinical evidence.
Are Exosomes Stem Cells?
No.
This distinction should be explicit.
Exosomes are not cells.
They therefore should not be marketed as:
“stem cells injected into your skin.”
They are extracellular vesicles associated with cell-to-cell signaling.
Can Exosomes Regenerate the Skin?
Research into exosomes and extracellular vesicles is active and scientifically interesting.
However, claims such as:
- Reverses aging
- Creates new skin
- Produces stem cells
- Permanently rejuvenates the face
- Repairs all cellular damage
go beyond what should be promised in aesthetic practice.
The exact product, source, manufacturing process and regulatory status are particularly important.
“STEM CELL” TREATMENTS IN AESTHETIC MEDICINE
The phrase “stem-cell facial treatment” is frequently used imprecisely.
Several completely different things can be marketed under this term.
For example:
- Fat grafting
- Nanofat
- Stromal-cell-related concepts
- Conditioned media
- Exosome products
are not synonymous.
A product should be described according to what it actually contains, rather than using “stem cell” as a universal marketing label.
Microfat and Nanofat
Autologous fat can also be used within facial rejuvenation strategies.
Microfat
Primarily has a structural volume-restoration role.
Nanofat
Is mechanically processed adipose tissue used differently from conventional volumizing fat grafting.
Nanofat should not simply be called:
“stem-cell injection.”
Its composition and biological effects are more complex than that marketing description suggests.
Injectables vs Microneedling
An injectable treatment introduces a material into tissue.
Microneedling creates controlled mechanical microinjury.
These mechanisms are different.
They may sometimes be combined, but combination should have a reason.
More procedures in the same session do not automatically produce a better result.
Skin-quality Injections vs Laser
Injectable treatments and lasers address different components of skin aging.
Laser resurfacing can directly influence:
- Epidermal surface
- Texture
- Selected scars
- Photodamage
- Dermal remodeling
Injectables may target:
- Hydration
- Extracellular matrix environment
- Selected biological skin-quality pathways
For some patients, one modality is enough.
For others, staged combination treatment may be more appropriate.
Skin-quality Treatments vs Facelift
No injectable skin-quality product can anatomically reproduce a facelift.
If the primary problem is:
- Jowling
- Significant lower-face descent
- Neck laxity
- Deep tissue displacement
the problem is not simply poor skin quality.
Similarly, facelift surgery does not directly correct every:
- Fine wrinkle
- Pigment abnormality
- Surface texture problem
The treatments work at different anatomical levels.
WHAT ABOUT THE “GLOW”?
Patients frequently request treatments for “glow.”
This is understandable but medically nonspecific.
Perceived skin brightness can be influenced by:
- Hydration
- Surface smoothness
- Pigmentation
- Sebum
- Vascularity
- Light reflection
Therefore, there is no single “glow injection” appropriate for everyone.
How Many Sessions Are Needed?
There is no universal answer across this category.
PN/PDRN, PRP, HA-based skin boosters, amino-acid formulations and other treatments have different protocols.
More importantly, patients respond differently.
Treatment should not be reduced to:
“Buy three sessions because everyone needs three.”
Response should be reassessed over time.
Are Results Permanent?
Generally, no.
Skin continues to age.
Treatment effects can also change as:
- Injected materials are metabolized
- Hydration changes
- Tissue remodeling evolves
- Environmental exposure continues
Maintenance can be considered according to the treatment and response.
Risks
Risks depend on the specific procedure and product but can include:
- Bruising
- Swelling
- Redness
- Tenderness
- Infection
- Inflammatory reactions
- Nodules
- Product-related reactions
- Pigment alteration
- Prolonged edema
Injectable treatments can also have anatomy-dependent vascular and tissue risks.
“Non-surgical” does not mean “risk-free.”
DR. FATIH CERAN'S APPROACH TO SKIN QUALITY
Treatment should not begin with:
“Which brand should we inject?”
The first question is:
What exactly is wrong with the skin?
Is the problem:
Hydration?
Fine texture?
Photodamage?
Pigmentation?
Fine wrinkling?
Scarring?
Loss of elasticity?
Periorbital skin quality?
Or is the apparent “skin problem” actually:
Volume loss?
Muscle activity?
Facial descent?
Eyelid ptosis?
Brow ptosis?
Fat prolapse?
Skeletal deficiency?
Once the anatomical problem is identified, the next question is:
What treatment mechanism is required?
Hydration?
Resurfacing?
Mechanical remodeling?
Volume restoration?
Neuromuscular modulation?
Biostimulatory treatment?
Surgery?
Only then should the product be selected.
The sequence is:
diagnosis → anatomical level → biological target → treatment category → product → technique → reassessment.
The objective is not to use every available product.
It is to determine which treatment the patient actually needs—and which treatments they do not.
Frequently Asked Questions About Skin Quality Treatments
What is the best treatment for skin quality?
There is no single best treatment. The appropriate option depends on whether the main problem is hydration, texture, pigmentation, scarring, fine wrinkling or another condition.
Is salmon DNA the same as polynucleotide treatment?
“Salmon DNA” is a popular term used for some PN/PDRN-related products. The exact formulation is more clinically meaningful than the marketing name.
Do polynucleotides change my DNA?
No. They do not rewrite the patient's genetic code.
Are polynucleotides fillers?
They are not conventional structural volumizing fillers.
What is the difference between PN and PDRN?
They refer to related but not automatically identical nucleotide-based materials. Commercial formulations can differ substantially.
What is a skin booster?
It is an injectable treatment category intended primarily to improve skin characteristics such as hydration and texture rather than create major structural volume.
Is Jalupro a filler?
Its role is primarily within skin-quality injectable treatment rather than conventional structural facial volumization.
Is PRP a stem-cell treatment?
No. PRP is a platelet-rich preparation derived from the patient's own blood.
Are exosomes stem cells?
No. Exosomes are extracellular vesicles, not cells.
Are regenerative treatments permanent?
Generally not. Skin continues to age and treatment effects evolve over time.
Can these treatments replace a facelift?
No. They cannot reposition significantly descended facial tissues.
Which treatment should I choose?
The choice should follow diagnosis of the actual skin and anatomical problem rather than product popularity.